简
繁
EN
简
繁
EN
Home
Latest
Finance
IPO
ETF
Technology
Overseas
Research
HOME
·
Samsung Blockchain Technologies ETF
Samsung Blockchain Technologies ETF (03171.HK) Rises 4.41% to HKD 45.500
Tags:
Samsung Blockchain Technologies ETF
03171.HK
ETF
2026-07-21
Samsung Blockchain Technologies ETF (03171.HK) Falls 4.54%, Turnover Reaches HKD 4,500
Tags:
Samsung Blockchain Technologies ETF
ETF
03171.HK
2026-07-17
Samsung Blockchain Technologies ETF (03171.HK) Falls 3.84% to HKD 48.560
Tags:
Samsung Blockchain Technologies ETF
03171.HK
ETF
2026-06-04
Samsung Blockchain Technologies ETF (03171.HK) Rises 3.35% to HKD 48.100
Tags:
Samsung Blockchain Technologies ETF
03171.HK
ETF
2026-05-22
Samsung Blockchain Technologies ETF (03171.HK) Rises 0.44%, Trades at 1.81% Premium
Tags:
Samsung Blockchain Technologies ETF
03171.HK
ETF
2026-04-22
Samsung Blockchain Technologies ETF (03171.HK) rose 6.94% today, bringing its one-year cumulative change to 55.26%
Tags:
Samsung Blockchain Technologies ETF
ETF
03171.HK
2026-04-14
Cryptocurrencies Continue to Decline, Samsung Blockchain Technologies ETF (03171.HK) Drops Nearly 6% in Early Trading
Tags:
ETF
03171.HK
Samsung Blockchain Technologies ETF
2026-02-05
Featured News
Research
HK Stock Connect Weekly Report: Hang Seng Index Rises 3.55% for the Week; Quarterly Review Results Unveiled, HUA HONG GRACE and ILUVATAR COREX Enter HSI and HSTECH - 20260821
Research
Going Global Weekly Report: Pharma Overseas Expansion Blossoms Across Fronts, A-Share Companies Accelerate Hong Kong Listings - 20260821
Research
HK Stock Connect Daily Report: MINIMAX-W Up Nearly 12%, Z.AI Up Over 10%, Southbound Net Sell of HKD 7.6 Billion - 20260821
Finance
Ingenic Semiconductor (03223.HK): H-Shares Offer Price Set at HK$100 Per Share
Finance
MOBVOI (02438.HK): Expects H1 Loss of RMB 45-58 Million
Finance
FAR INTL (02516.HK): Expects H1 Revenue Up 61%-110% and Turnaround or Narrower Loss
Finance
SHANDONG XINHUA (00719.HK): Obtains Drug Registration Certificate for Dapagliflozin Tablets
Finance
LEADS BIOLABS-B (09887.HK): NDA for Virexin as Treatment for Extrapulmonary Neuroendocrine Carcinoma Accepted by NMPA
Finance
SC HOLDINGS (00413.HK): Expects H1 Net Loss of HKD 400-500 Million
Finance
HK shares ETFs Daily Report: Gold Miners Extend Gains 5.7%! Blockchain and Korea Counterattack in Tandem, Biomedicine and MedTech Lead Declines - 20260821
Scan QR Code
Download App